Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2025

Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation.

View Full Paper
Ask AI
Bookmark
Share

Authors

SASankalp AroraWJWei‐Ying JenMYMusa Yılmaz

Discussion

Loading...

Member takes

Overview

Retrospective study highlights overall survival differences in acute myeloid leukemia patients with FLT3 mutations, suggesting targeted stem cell treatments.

Key Points

  • Overall survival for patients with FLT3-TKDmut AML was 56%, with significant implications for treatment strategies.
  • NPM1 co-mutation was found in 44% of FLT3-TKDmut patients, correlating with improved overall survival rates of 74%.
  • Allogeneic stem cell transplantation dramatically improved overall survival in patients with NPM1wt AML compared to those with NPM1 mutations.
  • Differences in chemotherapy intensity show no overall survival advantage for NPM1mut/FLT3-TKDwt patients between treatment regimens.

Cite This Study

Arora et al. (2025) studied this question.

synapsesocial.com/papers/689fc3ee735da01f534db987https://doi.org/10.1002/cncr.70032
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic factors for newly diagnosed Acute Myeloid Leukemia with FLT3-TKD - a multicenter retrospective study2025
  2. 2Prognostic covariates associated with outcomes in patients with <i>NPM1</i>-mutated acute myeloid leukemia2025 · 3 citations
  3. 3Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with <i>NPM1</i> mutated de novo acute myeloid leukemia.2024
  4. 4Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: Insights from real-world genomic data2025
  5. 5DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors2025 · 3 citations